Search research articles
Contact Us
Filters
Showing results (41-50 of 68) with videos related to
Page
of 7
Sort By:
Breast Cancer Research and Treatment
|
April 2, 2017
Frailty and long-term mortality of older breast cancer patients: CALGB 369901 (Alliance)
Jeanne S Mandelblatt, Ling Cai, George Luta, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 1, 2008
Randomized phase III trial of weekly compared with every-3-weeks paclitaxel for metastatic breast cancer, with trastuzumab for all HER-2 overexpressors and random assignment to trastuzumab or not in HER-2 nonoverexpressors: final results of Cancer and Leukemia Group B protocol 9840
Andrew D Seidman, Donald Berry, Constance Cirrincione, et al.
Journal of the National Cancer Institute
|
November 30, 2014
Generalizability of trial results to elderly Medicare patients with advanced solid tumors (Alliance 70802)
Elizabeth B Lamont, Richard L Schilsky, Yulei He, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 13, 2018
Quality of Life From Canadian Cancer Trials Group MA.17R: A Randomized Trial of Extending Adjuvant Letrozole to 10 Years
Julie Lemieux, Michael D Brundage, Wendy R Parulekar, et al.
Journal of Geriatric Oncology
|
August 8, 2021
Disparities in older adult accrual to cancer trials: Analysis from the alliance for clinical trials in oncology (A151736)
Noam A VanderWalde, Travis Dockter, Daniel V Wakefield, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 30, 2008
Racial differences in clinical outcomes from metastatic breast cancer: a pooled analysis of CALGB 9342 and 9840--Cancer and Leukemia Group B
Blase N Polite, Constance Cirrincione, Gini F Fleming, et al.
Breast Cancer Research and Treatment
|
June 15, 2006
Interleukin-6, multidrug resistance protein-1 expression and response to paclitaxel in women with metastatic breast cancer: results of cancer and leukemia group B trial 159806
Mercedes Rincon, Gloria Broadwater, Lyndsay Harris, et al.
The Lancet. Oncology
|
December 7, 2007
Management of breast cancer in elderly individuals: recommendations of the International Society of Geriatric Oncology
Hans Wildiers, Ian Kunkler, Laura Biganzoli, et al.
Journal of Geriatric Oncology
|
December 27, 2021
Phase Ib trial of lenalidomide as post-remission therapy for older adults with acute myeloid leukemia: Safety and longitudinal assessment of geriatric functional domains
Justin D Woods, Joshua F Zeidner, Hendrik W Van Deventer, et al.
JCO Clinical Cancer Informatics
|
April 14, 2021
Electronic Geriatric Assessment: Is It Feasible in a Multi-Institutional Study That Included a Notable Proportion of Older African American Patients? (Alliance A171603)
Emily Guerard, Andrew B Dodge, Jennifer G Le-Rademacher, et al.
Page
of 7
Search research articles
Search
Showing results (41-50 of 68) with videos related to
Sort By:
Page
of 7
Breast Cancer Research and Treatment
|
April 2, 2017
Frailty and long-term mortality of older breast cancer patients: CALGB 369901 (Alliance)
Jeanne S Mandelblatt, Ling Cai, George Luta, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 1, 2008
Randomized phase III trial of weekly compared with every-3-weeks paclitaxel for metastatic breast cancer, with trastuzumab for all HER-2 overexpressors and random assignment to trastuzumab or not in HER-2 nonoverexpressors: final results of Cancer and Leukemia Group B protocol 9840
Andrew D Seidman, Donald Berry, Constance Cirrincione, et al.
Journal of the National Cancer Institute
|
November 30, 2014
Generalizability of trial results to elderly Medicare patients with advanced solid tumors (Alliance 70802)
Elizabeth B Lamont, Richard L Schilsky, Yulei He, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 13, 2018
Quality of Life From Canadian Cancer Trials Group MA.17R: A Randomized Trial of Extending Adjuvant Letrozole to 10 Years
Julie Lemieux, Michael D Brundage, Wendy R Parulekar, et al.
Journal of Geriatric Oncology
|
August 8, 2021
Disparities in older adult accrual to cancer trials: Analysis from the alliance for clinical trials in oncology (A151736)
Noam A VanderWalde, Travis Dockter, Daniel V Wakefield, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 30, 2008
Racial differences in clinical outcomes from metastatic breast cancer: a pooled analysis of CALGB 9342 and 9840--Cancer and Leukemia Group B
Blase N Polite, Constance Cirrincione, Gini F Fleming, et al.
Breast Cancer Research and Treatment
|
June 15, 2006
Interleukin-6, multidrug resistance protein-1 expression and response to paclitaxel in women with metastatic breast cancer: results of cancer and leukemia group B trial 159806
Mercedes Rincon, Gloria Broadwater, Lyndsay Harris, et al.
The Lancet. Oncology
|
December 7, 2007
Management of breast cancer in elderly individuals: recommendations of the International Society of Geriatric Oncology
Hans Wildiers, Ian Kunkler, Laura Biganzoli, et al.
Journal of Geriatric Oncology
|
December 27, 2021
Phase Ib trial of lenalidomide as post-remission therapy for older adults with acute myeloid leukemia: Safety and longitudinal assessment of geriatric functional domains
Justin D Woods, Joshua F Zeidner, Hendrik W Van Deventer, et al.
JCO Clinical Cancer Informatics
|
April 14, 2021
Electronic Geriatric Assessment: Is It Feasible in a Multi-Institutional Study That Included a Notable Proportion of Older African American Patients? (Alliance A171603)
Emily Guerard, Andrew B Dodge, Jennifer G Le-Rademacher, et al.
Page
of 7